Bạn đang xem: P và
View press release & press conference.
Comirnaty Information Pfizer-BioNTech Fact Sheets Pfizer-BioNTech Fact Sheet Translations Información sobre las vacunas para el COVID-19
On August 23, 2021, khansar.net announced the first approval of a COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, và will now be marketed as Comirnaty, for the prevention of COVID-19 in individuals 16 years of age & older.
Pfizer-BioNTech COVID-19 Vaccine is authorized for emergency use as a:
Three-dose primary series for individuals 6 months through 4 years of age.Two-dose primary series for individuals 5 years of age & older.Third primary series dose for individuals 5 years of age & older who have been determined khổng lồ have certain kinds of immunocompromise.Single booster dose for individuals 5 through 11 years of age at least five months after completing a primary series of the Pfizer-BioNTech COVID-19 Vaccine.First booster dose for individuals 12 years of age and older at least five months after completing a primary series of the Pfizer-BioNTech COVID-19 Vaccine or Comirnaty vaccine.First booster dose for individuals 18 years of age & older who have completed primary vaccination with another authorized or approved COVID-19 vaccine. The dosing interval for this first booster dose is the same as that authorized for a booster dose of the vaccine used for primary vaccination.Second booster dose for individuals 50 years of age và older at least four months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.Second booster dose for individuals 12 years of age và older with certain kinds of immunocompromise at least four months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.Xem thêm: Nhạc Sĩ Nguyễn Hồng Thuận Là Ai Mà Bài Hát Của Anh Được Săn Đón
On February 11, 2022, in consultation with khansar.net, CDC updated the emergency use instructions to provide information about the primary, additional, and booster doses of the Pfizer COVID-19 vaccines in certain individuals.
Comirnaty Information
Package Insert (purple cap) | December 2021 |
Package Insert (gray cap) | December 2021 |
Approval Letter | August 23, 2021 |
Supplement Approval Letter | December 16, 2021 |
Summary Basis for Regulatory Action | November 8, 2021 |
FAQ for Comirnaty (COVID-19 Vaccine mRNA) (Español) | February 2, 2022 |
CDC-issued Emergency Use Instructions (updated) | February 11, 2022 |
Fact Sheet | Healthcare Providers | 6 months through 4 years, maroon cap (must dilute) | June 17, 2022 |
Dear Healthcare Provider Letter | Healthcare Providers | 6 months through 4 years, maroon cap (must dilute) | June 17, 2022 |
Fact Sheet | Recipients & Caregivers | 6 months through 4 years of age | June 17, 2022 |
Fact Sheet | Healthcare Providers | 5 years through 11 years of age, orange cap (must dilute) | June 17, 2022 |
Fact Sheet | Recipients & Caregivers | 5 years through 11 years of age | June 17, 2022 |
Fact Sheet | Healthcare Providers | 12 years of age và older, purple cap (must dilute) | June 17, 2022 |
Fact Sheet | Healthcare Providers | 12 years of age và older, gray cap (no dilution) | June 17, 2022 |
Fact Sheet | Recipients & Caregivers | 12 years of age và older | June 17, 2022 |
Wall Chart | Healthcare Providers | All | June 17, 2022 |
Frequently Asked Questions on the Pfizer-BioNTech COVID-19 Vaccine | All | All | February 16, 2022 |
Letter of Authorization (Reissued) | June 17, 2022 |
Letter Granting EUA Amendment | June 1, 2022 |
Decision Memorandum | May 17, 2022 |
Letter Granting EUA Amendment | April 26, 2022 |
Letter Granting EUA Amendment | April 13, 2022 |
Decision Memorandum | March 28, 2022 |
Letter Granting EUA Amendment | January 31, 2022 |
Decision Memorandum Addendum | January 6, 2022 |
Decision Memorandum | December 30, 2021 |
Decision Memorandum | December 8, 2021 |
Decision Memorandum Addendum | November 19, 2021 |
Decision Memorandum | November 19, 2021 |
Decision Memorandum | October 29, 2021 |
Advisory Committee Meeting Information | October 26, 2021 |
Decision Memorandum | October 20, 2021 |
Decision Memorandum | September 24, 2021 |
Advisory Committee Meeting Information | September 17, 2021 |
Letter Granting EUA Amendment | September 1, 2021 |
Concurrence Letter | August 22, 2021 |
Decision Memorandum | August 12, 2021 |
Letter Granting EUA Amendment | May 19, 2021 |
khansar.net Decision Memorandum | May 10, 2021 |
Letter Granting EUA Amendment | April 6, 2021 |
Letter Granting EUA Amendment | January 22, 2021 |
Letter Granting EUA Amendment | January 6, 2021 |
khansar.net Decision Memorandum | December 11, 2020 |
Advisory Committee Meeting Information | December 10, 2020 |
Press Conference | June 17, 2022 |
Press Release | June 17, 2022 |
Advisory Committee Webcast | June 15, 2022 |
Press Release | May 17, 2022 |
Media Call | March 29, 2022 |
Press Release | March 29, 2022 |
Press Release | January 3, 2022 |
Press Release | November 19, 2021 |
Press Release | October 29, 2021 |
Press Conference | October 29, 2021 |
Advisory Committee Webcast | October 26, 2021 |
Press Release | October 20, 2021 |
Media Call | October 20, 2021 |
Press Release | September 22, 2021 |
Advisory Committee Webcast | September 17, 2021 |
Press Release | August 23, 2021 |
Press Release | August 12, 2021 |
khansar.net In Brief | May 19, 2021 |
Press Release | May 10, 2021 |
Press Conference | May 10, 2021 |
Press Release | February 25, 2021 |
Press Release | December 11, 2020 |
Press Conference | December 11, 2020 |
Advisory Committee Webcast | December 10, 2020 |
Translations of the Pfizer-BioNTech Fact Sheet for Recipients và Caregivers for 5 through 11 years of age
HOJA INFORMATIVA DE VACUNAS PARA RECEPTORES Y CUIDADORES SOBRE LA VACUNA DE PFIZER-BIONTECH CONTRA EL COVID-19 PARA PREVENIR LA ENFERMEDAD DEL CORONAVIRUS 2019 (COVID-19) PARA USO EN PERSONAS DE 5 A 11 AÑOS(May 17, 2022) | 5 - 11 years of age | Español (Spanish) |
为接种者和护理者提供的关于用于预防2019新冠肺炎(COVID-19)的辉瑞生物技术公司2019新冠肺炎疫苗以个人使用的信息概况说明书 5岁至11岁 (May 17, 2022) | 5 - 11 years of age | 中文 (Chinese, Simplified) |
5 세에서 11 세에 해당하는사람들에게 코로나바이러스감염증 2019 (COVID-19)를 예방하기 위한화이저 (PFIZER)-바이오엔텍 (BIONTECH) 코비드-19 백신에 대한 환자와 의료진을 위한 백신 정보지(May 17, 2022) | 5 - 11 years of age | 한국어 (Korean) |
BAKUNA IMPORMASYON FACT SHEET PARA SA MGA TUMANGGAP AT MGA TAGAPAG-ALAGA TUNGKOL SA PFIZER-BIONTECH COVID-19 BAKUNA UPANG MAIWASAN ANG CORONAVIRUS DISEASE 2019 (COVID-19) PARA SA PAGGAMIT SA MGA INDIBIDWAL 5 HANGGANG 11 TAONG GULANG(May 17, 2022) | 5 - 11 years of age | Tagalog (Tagalog) |
BẢNG THÔNG TIN VỀ VẮC XIN DÀNH mang lại NGƯỜI NHẬN VÀ NGƯỜI CHĂM SÓC VỀ VẮC XIN PFIZER-BIONTECH COVID-19 NHẰM PHÒNG NGỪA BỆNH CORONAVIRUS 2019 (COVID-19) ĐỂ SỬ DỤNG mang lại CÁ NHÂN TỪ 5 TỚI 11 TUỔI (May 17, 2022) | 5 -11 years of age | Tiếng Việt (Vietnamese) |
Translations of the Pfizer-BioNTech Fact Sheet for Recipients và Caregivers for 12 years of age and older
HOJA INFORMATIVA DE VACUNAS PARA RECEPTORES Y CUIDADORES SOBRE COMIRNATY (VACUNA DE ARNm CONTRA EL COVID-19) Y LA VACUNA DE PFIZER-BIONTECH CONTRA EL COVID-19 PARA PREVENIR LA ENFERMEDAD DEL CORONAVIRUS 2019 (COVID-19) PARA USO EN PERSONAS DE 12 AÑOS O MÁS(May 17, 2022) | 12 years of age và older | Español (Spanish) |
关于复必泰 (2019核糖核酸新冠肺炎疫苗)以及辉瑞-BioNTech2019新冠肺炎疫苗预防2019新冠肺炎的接受者和护理者须知(May 17, 2022) | 12 years of age và older | 中文 (Chinese, Simplified) |
코로나바이러스감염증 2019 (COVID-19)를 예방하기 위한 코멀나티 (코비드-19 백신, 메신저 RNA)와 화이저 (PFIZER)-바이오엔텍 (BIONTECH) 코비드-19 백신에 대한 환자와 의료진을 위한 백신 정보지(May 17, 2022) | 12 years of age & older | 한국어 (Korean) |
FACT SHEET NG IMPORMASYON SA BAKUNA PARA SA MGA TANGGAP AT CAREGIVERS TUNGKOL SA COMIRNATY (COVID-19 VACCINE, mRNA)AT BAKUNA na PFIZER-BIONTECH COVID-19 UPANG MAIWASAN ANG CORONAVIRUS DISEASE 2019 (COVID-19)(May 17, 2022) | 12 years of age & older | Tagalog (Tagalog) |
TỜ DỮ KIỆN THÔNG TIN VỀ VẮC XIN DÀNH đến NGƯỜI NHẬN VÀ NGƯỜI CHĂM SÓC VỀ COMIRNATY (VẮC XIN COVID-19, mRNA)VÀ VẮC XIN PFIZER-BIONTECH COVID-19 ĐỂ PHÒNG NGỪA BỆNH CORONAVIRUS 2019 (COVID-19)(May 17, 2022) | 12 years of age & older | Tiếng Việt (Vietnamese) |